Journal
Alzheimer's Research & Therapy
Publication Date
2016
Volume
8
Inclusive Pages
39
Document Type
Open Access Publication
DOI
10.1186/s13195-016-0207-9
Rights and Permissions
Cummings et al. Alzheimer's Research & Therapy (2016) 8:39 DOI 10.1186/s13195-016-0207-9 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Recommended Citation
Cummings, Jeffrey; Aisen, Paul S.; DuBois, Bruno; Frölich, Lutz; Jack, Clifford R. Jr.; Jones, Roy W.; Morris, John C.; Raskin, Joel; Dowsett, Sherie A.; and Scheltens, Philip, "Drug development in Alzheimer’s disease: The path to 2025." Alzheimer's Research & Therapy. 8, 39. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5285
